The FDA is susceptible to a reshuffle under President-elect Donald Trump, whose plans to “Make America Healthy Again” would have ramifications for an agency responsible for drug approvals and food and cosmetics safety.
“I expect him to put a firm hand on agencies like the FDA,” said Lawrence Gostin, co-faculty director of the O’Neill Institute for National and Global Health Law. “Trump has made very clear that he wants to influence, if not control, federal health and scientific agencies.”
Trump hasn’t revealed details of his agenda, but his promise to allow vaccine skeptic Robert F. Kennedy Jr. to “go ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.